Go Pro

Astrana Health (NASDAQ:ASTH) Rating Lowered to Hold at Wall Street Zen

Astrana Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen downgraded Astrana Health from “Buy” to “Hold,” though the broader analyst consensus remains “Moderate Buy,” with seven Buy ratings and two Hold ratings.
  • Analysts have raised their price targets in recent reports, including BTIG Research to $65, Truist Financial to $55, and TD Cowen to $50; the consensus target is $49.43.
  • Astrana Health shares were trading at $40.81, up 8%, with a market capitalization of approximately $2.27 billion. Institutional investors and hedge funds own 52.77% of the company.
  • Five stocks we like better than Astrana Health.

Astrana Health (NASDAQ:ASTH - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report released on Sunday.

Several other equities research analysts also recently weighed in on the stock. Robert W. Baird set a $45.00 target price on shares of Astrana Health in a research note on Friday, May 8th. Needham & Company LLC boosted their price target on Astrana Health from $30.00 to $41.00 and gave the company a "buy" rating in a research report on Friday, May 8th. TD Cowen upped their price objective on Astrana Health from $45.00 to $50.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. BTIG Research upped their price objective on Astrana Health from $50.00 to $65.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Finally, Truist Financial increased their price objective on Astrana Health from $47.00 to $55.00 and gave the stock a "buy" rating in a research report on Monday, August 10th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $49.43.

Check Out Our Latest Stock Report on Astrana Health

Astrana Health Trading Up 8.0%

Shares of Astrana Health stock opened at $40.81 on Friday. The company has a market cap of $2.27 billion, a P/E ratio of 49.77 and a beta of 0.87. The firm has a 50-day simple moving average of $41.34 and a two-hundred day simple moving average of $32.83. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.35 and a current ratio of 1.23. Astrana Health has a fifty-two week low of $18.08 and a fifty-two week high of $51.60.

Institutional Trading of Astrana Health

Several hedge funds have recently made changes to their positions in ASTH. Great Lakes Advisors LLC acquired a new position in shares of Astrana Health during the second quarter worth about $832,000. Diamond Hill Capital Management LLC Investment Advisor acquired a new stake in Astrana Health in the second quarter valued at about $22,088,000. Bank of New York Mellon Corp acquired a new stake in Astrana Health in the second quarter valued at about $10,902,000. Bank of America Corp DE boosted its holdings in Astrana Health by 13.3% in the 1st quarter. Bank of America Corp DE now owns 574,729 shares of the company's stock valued at $14,092,000 after purchasing an additional 67,628 shares in the last quarter. Finally, Edgestream Partners L.P. boosted its holdings in Astrana Health by 68.3% in the 1st quarter. Edgestream Partners L.P. now owns 27,616 shares of the company's stock valued at $677,000 after purchasing an additional 11,209 shares in the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Read More

Analyst Recommendations for Astrana Health (NASDAQ:ASTH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Astrana Health Right Now?

Before you consider Astrana Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.

While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines